Oklahoma SB927 modifies the appointment procedures for the Medicaid Drug Utilization Review Board.
Oklahoma SB927 amends the appointment procedures for the Medicaid Drug Utilization Review Board within the Oklahoma Health Care Authority. The board consists of ten members, including a physician, four pharmacists, a lay community representative, and a pharmaceutical industry representative. The bill updates the statutory language and specifies the appointment terms and procedures. Members may serve up to three three-year terms, with staggered two-year terms for the pharmaceutical industry representative.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.